Global Whole Cell Cholera Vaccine Market Research Report 2019

Table of Contents

Executive Summary

1 Whole Cell Cholera Vaccine Market Overview

• 1.1 Product Overview and Scope of Whole Cell Cholera Vaccine
• 1.2 Whole Cell Cholera Vaccine Segment by Type
  • 1.2.1 Global Whole Cell Cholera Vaccine Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 For Adults
  • 1.2.3 For Children
• 1.3 Whole Cell Cholera Vaccine Segment by Application
  • 1.3.1 Whole Cell Cholera Vaccine Consumption Comparison by Application (2014-2025)
  • 1.3.2 Clinical Research Institutes
  • 1.3.3 Hospital
  • 1.3.4 Surgical Centers
  • 1.3.5 Others
• 1.4 Global Whole Cell Cholera Vaccine Market by Region
  • 1.4.1 Global Whole Cell Cholera Vaccine Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Whole Cell Cholera Vaccine Market Size
  • 1.5.1 Global Whole Cell Cholera Vaccine Revenue (2014-2025)
  • 1.5.2 Global Whole Cell Cholera Vaccine Production (2014-2025)

2 Global Whole Cell Cholera Vaccine Market Competition by Manufacturers

• 2.1 Global Whole Cell Cholera Vaccine Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Whole Cell Cholera Vaccine Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Whole Cell Cholera Vaccine Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Whole Cell Cholera Vaccine Production Sites, Area Served, Product Types
• 2.5 Whole Cell Cholera Vaccine Market Competitive Situation and Trends
  • 2.5.1 Whole Cell Cholera Vaccine Market Concentration Rate
  • 2.5.2 Whole Cell Cholera Vaccine Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Whole Cell Cholera Vaccine Production Market Share by Regions

• 3.1 Global Whole Cell Cholera Vaccine Production Market Share by Regions
• 3.2 Global Whole Cell Cholera Vaccine Revenue Market Share by Regions (2014-2019)
• 3.3 Global Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Whole Cell Cholera Vaccine Production
  • 3.4.1 North America Whole Cell Cholera Vaccine Production Growth Rate (2014-2019)
  • 3.4.2 North America Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Whole Cell Cholera Vaccine Production
  • 3.5.1 Europe Whole Cell Cholera Vaccine Production Growth Rate (2014-2019)
  • 3.5.2 Europe Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Whole Cell Cholera Vaccine Production (2014-2019)
  • 3.6.1 China Whole Cell Cholera Vaccine Production Growth Rate (2014-2019)
  • 3.6.2 China Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Whole Cell Cholera Vaccine Production (2014-2019)
  • 3.7.1 Japan Whole Cell Cholera Vaccine Production Growth Rate (2014-2019)
  • 3.7.2 Japan Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Whole Cell Cholera Vaccine Consumption by Regions

• 4.1 Global Whole Cell Cholera Vaccine Consumption by Regions
• 4.2 North America Whole Cell Cholera Vaccine Consumption (2014-2019)
• 4.3 Europe Whole Cell Cholera Vaccine Consumption (2014-2019)
• 4.4 China Whole Cell Cholera Vaccine Consumption (2014-2019)
• 4.5 Japan Whole Cell Cholera Vaccine Consumption (2014-2019)

5 Global Whole Cell Cholera Vaccine Production, Revenue, Price Trend by Type

• 5.1 Global Whole Cell Cholera Vaccine Production Market Share by Type (2014-2019)
• 5.2 Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2014-2019)
• 5.3 Global Whole Cell Cholera Vaccine Price by Type (2014-2019)
• 5.4 Global Whole Cell Cholera Vaccine Production Growth by Type (2014-2019)

6 Global Whole Cell Cholera Vaccine Market Analysis by Applications

• 6.1 Global Whole Cell Cholera Vaccine Consumption Market Share by Application (2014-2019)
• 6.2 Global Whole Cell Cholera Vaccine Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Whole Cell Cholera Vaccine Business

• 7.1 SBL Vaccine
  • 7.1.1 SBL Vaccine Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.1.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.1.3 SBL Vaccine Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 PaxVax
  • 7.2.1 PaxVax Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.2.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.2.3 PaxVax Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Valneva SE
  • 7.3.1 Valneva SE Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.3.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.3.3 Valneva SE Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 GlaxoSmithKline
  • 7.4.1 GlaxoSmithKline Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.4.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.4.3 GlaxoSmithKline Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Johnson and Johnson
  • 7.5.1 Johnson and Johnson Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.5.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.5.3 Johnson and Johnson Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Merck
  • 7.6.1 Merck Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.6.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.6.3 Merck Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Pfizer
  • 7.7.1 Pfizer Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.7.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.7.3 Pfizer Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Sanofi Pasteur
  • 7.8.1 Sanofi Pasteur Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.8.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.8.3 Sanofi Pasteur Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 AstraZeneca(Medimmune, LLC.)
  • 7.9.1 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.9.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.9.3 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Serum Institute of India
  • 7.10.1 Serum Institute of India Whole Cell Cholera Vaccine Production Sites and Area Served
  • 7.10.2 Whole Cell Cholera Vaccine Product Introduction, Application and Specification
  • 7.10.3 Serum Institute of India Whole Cell Cholera Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Whole Cell Cholera Vaccine Manufacturing Cost Analysis

• 8.1 Whole Cell Cholera Vaccine Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Whole Cell Cholera Vaccine
• 8.4 Whole Cell Cholera Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Whole Cell Cholera Vaccine Distributors List
• 9.3 Whole Cell Cholera Vaccine Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Whole Cell Cholera Vaccine Market Forecast

• 11.1 Global Whole Cell Cholera Vaccine Production, Revenue Forecast
  • 11.1.1 Global Whole Cell Cholera Vaccine Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Whole Cell Cholera Vaccine Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Whole Cell Cholera Vaccine Price and Trend Forecast (2019-2025)
• 11.2 Global Whole Cell Cholera Vaccine Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Whole Cell Cholera Vaccine Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Whole Cell Cholera Vaccine Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Whole Cell Cholera Vaccine Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Whole Cell Cholera Vaccine Production, Revenue Forecast (2019-2025)
• 11.3 Global Whole Cell Cholera Vaccine Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Whole Cell Cholera Vaccine Consumption Forecast (2019-2025)
  • 11.3.2 Europe Whole Cell Cholera Vaccine Consumption Forecast (2019-2025)
  • 11.3.3 China Whole Cell Cholera Vaccine Consumption Forecast (2019-2025)
  • 11.3.4 Japan Whole Cell Cholera Vaccine Consumption Forecast (2019-2025)
• 11.4 Global Whole Cell Cholera Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Whole Cell Cholera Vaccine Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List